Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Palla

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The FEBS Journal|December 22, 2005
The natural mutation by deletion of Lys9 in the thrombin A-chain affects the pKa value of catalytic residues, the overall enzyme's stability and conformational transitions linked to Na+ bindingRaimondo De Cristofaro, Andrea Carotti, Sepideh Akhavan, et al.
British Journal of Haematology|November 30, 2004
The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiencyFlora Peyvandi, Raimondo De Cristofaro, Isabella Garagiola, et al.
Thrombosis and Haemostasis|March 13, 2019
Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP RegistryIlaria Mancini, Silvia Pontiggia, Roberta Palla, et al.
Thrombosis Research|August 30, 2011
B and T lymphocytes in acquired thrombotic thrombocytopenic purpura during disease remissionMariagabriella Mariani, Andrea Cairo, Roberta Palla, et al.
Thrombosis Research|January 8, 2014
A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular traffickingMarzia Menegatti, Anna Vangone, Roberta Palla, et al.
Human Mutation|February 3, 2006
Mechanisms of the interaction between two ADAMTS13 gene mutations leading to severe deficiency of enzymatic activityFlora Peyvandi, Silvia Lavoretano, Roberta Palla, et al.
Thrombosis Update|April 15, 2024
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2Flora Peyvandi, Erica Scalambrino, Marigrazia Clerici, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 10, 2023
Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficienciesSamin Mohsenian, Omid Seidizadeh, Roberta Palla, et al.
Haematologica|January 1, 2009
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpuraRoberta Palla, Silvia Lavoretano, Rossana Lombardi, et al.
British Journal of Haematology|December 14, 2020
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia AFlora Peyvandi, Syna Miri, Paolo Bucciarelli, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The FEBS Journal|December 22, 2005
The natural mutation by deletion of Lys9 in the thrombin A-chain affects the pKa value of catalytic residues, the overall enzyme's stability and conformational transitions linked to Na+ bindingRaimondo De Cristofaro, Andrea Carotti, Sepideh Akhavan, et al.
British Journal of Haematology|November 30, 2004
The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiencyFlora Peyvandi, Raimondo De Cristofaro, Isabella Garagiola, et al.
Thrombosis and Haemostasis|March 13, 2019
Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP RegistryIlaria Mancini, Silvia Pontiggia, Roberta Palla, et al.
Thrombosis Research|August 30, 2011
B and T lymphocytes in acquired thrombotic thrombocytopenic purpura during disease remissionMariagabriella Mariani, Andrea Cairo, Roberta Palla, et al.
Thrombosis Research|January 8, 2014
A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular traffickingMarzia Menegatti, Anna Vangone, Roberta Palla, et al.
Human Mutation|February 3, 2006
Mechanisms of the interaction between two ADAMTS13 gene mutations leading to severe deficiency of enzymatic activityFlora Peyvandi, Silvia Lavoretano, Roberta Palla, et al.
Thrombosis Update|April 15, 2024
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2Flora Peyvandi, Erica Scalambrino, Marigrazia Clerici, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 10, 2023
Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficienciesSamin Mohsenian, Omid Seidizadeh, Roberta Palla, et al.
Haematologica|January 1, 2009
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpuraRoberta Palla, Silvia Lavoretano, Rossana Lombardi, et al.
British Journal of Haematology|December 14, 2020
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia AFlora Peyvandi, Syna Miri, Paolo Bucciarelli, et al.
Pageof 5